Skip to Content
MilliporeSigma
All Photos(1)

Documents

EMU063671

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Apmap

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TTGAGGGCAAGAAGATGTCCTTTGTGAATGACCTCACTGTTACTCGGGATGGAAGGAAGATTTATTTCACGGATTCCAGCAGCAAGTGGCAGAGACGAGACTACCTGCTTCTGGTGATGGAGGCCACTGATGATGGGCGCCTGTTAGAGTATGATACTGTGACGAAAGAAGTGAAGGTTTTGTTGGACCAGTTGCAGTTCCCTAATGGAGTTCAGCTCTCTCCTGAGGAAGACTTTGTCCTAGTGGCAGAGACAACTATGGCCAGGATACGAAGAGTCTATGTGTCTGGCCTGATGAAAGGAGGGGCAGATATGTTTGTGGAGAACATGCCTGGATTTCCTGACAATATCCGGCCTAGCAGCTCTGGCGGATACTGGGTTGCTGCTGCAACCATTCGTGCTAACCCTG

Ensembl | mouse accession no.

ENSMUSG00000033096

NCBI accession no.

NM_027977

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... APMAP(71881) , 2310001A20Rik(71881)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Yuhang Ma et al.
Journal of proteome research, 15(2), 628-637 (2016-01-16)
Gestational diabetes mellitus (GDM) is considered as an early stage of type 2 diabetes mellitus. In this study, we compared demographic and clinical data between six GDM subjects and six normal glucose tolerance (NGT; healthy controls) subjects and found that
Sebastien Mosser et al.
Human molecular genetics, 24(2), 371-382 (2014-09-03)
The deposition of amyloid-beta (Aβ) aggregates in the brain is a major pathological hallmark of Alzheimer's disease (AD). Aβ is generated from the cleavage of C-terminal fragments of the amyloid precursor protein (APP-CTFs) by γ-secretase, an intramembrane-cleaving protease with multiple

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service